Search Result "Pan-cancer analysis"
Pan-cancer Analysis Identifies AIMP2 as a Potential Biomarker forBreast Cancer
Journal: Current Genomics
Volume: 24 Issue: 5 Year: 2023 Page: 307-329
Author(s):
Integrated Analysis of Clinical Outcome of Mesenchymal StemCell-related Genes in Pan-cancer
Journal: Current Genomics
Volume: 25 Issue: 4 Year: 2024 Page: 298-315
Author(s):
Pan-Cancer Analysis of Histone Methyltransferase KMT2D with PotentialImplications for Prognosis and Immunotherapy in Human Cancer
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 26 Issue: 1 Year: 2023 Page: 83-92
Author(s):
Pan-Cancer Analysis of CENPA as a Potential Prognostic and ImmunologicalBiomarker in Human Cancer
Journal: Current Bioinformatics
Volume: 17 Issue: 7 Year: 2022 Page: 599-614
Author(s):
TPD52 is a Potential Prognostic Biomarker and Correlated withImmune Infiltration: A Pan-cancer Analysis
Journal: Current Molecular Medicine
Volume: 24 Issue: 11 Year: 2024 Page: 1413-1425
Author(s):
Identification of Cancer Trait Genes and Association Analysis Under Pan-Cancer
Journal: Current Bioinformatics
Volume: 16 Issue: 8 Year: 2021 Page: 1101-1114
Author(s): Shudong Wang,Yuanyuan Zhang,Hongting Mu,Shanchen Pang
A Pan-cancer Analysis Reveals the Abnormal Expression and Drug Sensitivity of CSF1
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 7 Year: 2022 Page: 1296-1312
Author(s): Xiaoshuo Dai,Xinhuan Chen,Wei Chen,Yihuan Chen,Jun Zhao,Qiushuang Zhang,Jing Lu
Serine Protease 27, a Prognostic Biomarker in Pan-cancer andAssociated with the Aggressive Progression of Breast Cancer
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 15 Year: 2024 Page: 2073-2089
Author(s):
A Pan-cancer Analysis to Determine the Prognostic Analysis and ImmuneInfiltration of HSPA5
Journal: Current Cancer Drug Targets
Volume: 24 Issue: 1 Year: 2024 Page: 14-27
Author(s):
A Pan-Cancer Signature For S100A11 - Prognostic And ImmunotherapeuticValue
Journal: Current Proteomics
Volume: 20 Issue: 1 Year: 2023 Page: 62-74
Author(s):